In the latest quarter, 6 analysts provided ratings for Merit Medical Systems (NASDAQ:MMSI), showcasing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	4	2	0	0	0
Last 30D	1	0	0	0	0
1M Ago	1	0	0	0	0
2M Ago	1	0	0	0	0
3M Ago	1	2	0	0	0

In the assessment of 12-month price targets, analysts unveil insights for Merit Medical Systems, presenting an average target of $101.33, a high estimate of $108.00, and a low estimate of $93.00. Observing a downward trend, the current average is 1.43% lower than the prior average price target of $102.80.

Analyzing Analyst Ratings: A Detailed Breakdown

In examining recent analyst actions, we gain insights into how financial experts perceive Merit Medical Systems. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Sam Eiber	BTIG	Announces	Buy	$107.00	-
Mike Matson	Needham	Maintains	Buy	$108.00	$108.00
Jon Young	Canaccord Genuity	Raises	Buy	$99.00	$93.00
Michael Petusky	Barrington Research	Maintains	Outperform	$106.00	$106.00
Jon Young	Canaccord Genuity	Lowers	Buy	$93.00	$104.00
Larry Biegelsen	Wells Fargo	Lowers	Overweight	$95.00	$103.00

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Merit Medical Systems. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Merit Medical Systems compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Merit Medical Systems's stock. This examination reveals shifts in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Merit Medical Systems's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Merit Medical Systems analyst ratings.

Unveiling the Story Behind Merit Medical Systems

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Merit Medical Systems: Financial Performance Dissected

Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

Positive Revenue Trend: Examining Merit Medical Systems's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.04% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 7.22%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.84%, the company may need to address challenges in generating satisfactory returns for shareholders.

Return on Assets (ROA): Merit Medical Systems's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.06% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: With a below-average debt-to-equity ratio of 0.54, Merit Medical Systems adopts a prudent financial strategy, indicating a balanced approach to debt management.

Analyst Ratings: Simplified

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.